{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:02Z","timestamp":1792783322883,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kanazawa University","id":[{"id":"https:\/\/ror.org\/02hwp6a56","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Myocardial metabolism and perfusion in patients with ischemic heart disease or cardiomyopathy can be simultaneously assessed using\n                      <jats:sup>123<\/jats:sup>\n                      I-\u03b2-methyl-iodophenyl-pentadecanoic acid (BMIPP) and\n                      <jats:sup>201<\/jats:sup>\n                      Thallium (Tl) dual-isotope images. However, cross-contaminated counts between these tracers complicate quantitative analyses, particularly of\n                      <jats:sup>123<\/jats:sup>\n                      I-BMIPP washout rates (WRs). We developed a simplified method to determine WRs corrected for energy spectral crosstalk from dual-isotope images.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Our correction method was based on fixed energy-spectrum spill-in ratios (iRatio for\n                      <jats:sup>123<\/jats:sup>\n                      I and tRatio for\n                      <jats:sup>201<\/jats:sup>\n                      Tl) that were empirically determined from phantom and patient datasets. These ratios were applied to separate\n                      <jats:sup>123<\/jats:sup>\n                      I and\n                      <jats:sup>201<\/jats:sup>\n                      Tl counts in 38 studies of 36 patients with ischemic heart disease using dual-energy planar and single-photon emission computed tomography (SPECT) images. We calculated WRs before and after correction using early and late anterior planar images, as well as mean tomographic counts derived from polar maps. Thresholds of 5% (planar) and 10% (SPECT) were used to assess classification agreement between corrected and uncorrected WRs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The range of iRatios was 0.57\u20130.73 and that of tRatios was 0.10\u20130.12. Higher iRatio values were associated with greater body-weight patients, whereas tRatios were relatively stable regardless of body weight. The corrected\n                      <jats:sup>123<\/jats:sup>\n                      I-BMIPP WR depends primarily on tRatio and, by formulation, is not directly affected by iRatio. Using a fixed tRatio of 0.12, the correction method revealed strong correlations between corrected and uncorrected WRs for planar imaging (R\u00b2 = 0.969,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and SPECT (R\u00b2 = 0.964,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Corrected\n                      <jats:sup>123<\/jats:sup>\n                      I-BMIPP WRs were comparable to uncorrected values for both planar imaging (mean difference, \u2212\u20091.4%) and SPECT (mean difference, 0.8%). Among the 38 studies, classification of tentative normal versus abnormal WRs remained concordant in 35 (92%) planar studies and 36 (95%) SPECT studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our simplified energy spectrum\u2013based method demonstrated that correction of\n                      <jats:sup>123<\/jats:sup>\n                      I-BMIPP WRs is feasible under dual-isotope conditions. Although uncorrected WRs may provide approximate estimates, correction is important for reliable quantitative use of dual-isotope datasets, where spectral cross-talk limits accuracy. The proposed model-based approach improves the robustness and interpretability of WR assessment and enables practical, standardized quantitation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12149-026-02235-8","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:58:46Z","timestamp":1780127926000},"page":"1197-1209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Energy spectrum-based correction of washout rates in dual-isotope 123I-BMIPP\/201Tl imaging"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-8746","authenticated-orcid":false,"given":"Kenichi","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotoku","family":"Makida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Shibutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"2235_CR1","first-page":"471","volume":"40","author":"R Hosokawa","year":"1999","unstructured":"Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hirai T, et al. Myocardial metabolism of 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease. J Nucl Med. 1999;40:471\u20138.","journal-title":"J Nucl Med"},{"key":"2235_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s12149-009-0307-8","volume":"23","author":"A Nakamura","year":"2009","unstructured":"Nakamura A, Momose M, Kondo C, Nakajima T, Kusakabe K, Hagiwara N. Ability of 201Tl and 123I-BMIPP mismatch to diagnose myocardial ischemia in patients with suspected coronary artery disease. Ann Nucl Med. 2009;23:793\u20138.","journal-title":"Ann Nucl Med"},{"key":"2235_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/RLU.0b013e31819a1f67","volume":"34","author":"Y Akutsu","year":"2009","unstructured":"Akutsu Y, Yamanaka H, Nishimura H, Hamazaki Y, Kaneko K, Kodama Y, et al. Thallium-201 and I-123 beta-methyl iodophenyl-pentadecanoic acid dual isotope single photon emission computed tomography for evaluating reperfusion injury after successful reperfusion therapy. Clin Nucl Med. 2009;34:213\u20135.","journal-title":"Clin Nucl Med"},{"key":"2235_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF03164986","volume":"8","author":"M Kawamoto","year":"1994","unstructured":"Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med. 1994;8:47\u201354.","journal-title":"Ann Nucl Med"},{"key":"2235_CR5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1253\/circj.66.1132","volume":"66","author":"N Yasugi","year":"2002","unstructured":"Yasugi N, Koyanagi S, Ohzono K, Sakai K, Matsumoto T, Sako S, et al. Comparative study of dobutamine stress echocardiography and dual single-photon emission computed tomography (thallium-201 and I-123 BMIPP) for assessing myocardial viability after acute myocardial infarction. Circ J. 2002;66:1132\u20138.","journal-title":"Circ J"},{"key":"2235_CR6","first-page":"757","volume":"37","author":"Y Fujibayashi","year":"1996","unstructured":"Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Yonekura Y, Tamaki N, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med. 1996;37:757\u201361.","journal-title":"J Nucl Med"},{"key":"2235_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1006167713330","volume":"15","author":"R Nohara","year":"1999","unstructured":"Nohara R, Hosokawa R, Hirai T, Okuda K, Ogino M, Fujibayashi Y, et al. Basic kinetics of 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in canine myocardium. Int J Card Imaging. 1999;15:11\u201320.","journal-title":"Int J Card Imaging"},{"key":"2235_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.17996\/anc.19-00106","volume":"5","author":"K Hirano","year":"2019","unstructured":"Hirano K, Higashi M, Miyauchi H, Takagi A, Ikeda Y, Nakano Y, et al. Increased Washout of 123I-BMIPP in Triglyceride Deposit Cardiomyovasculopathy (TGCV) with Severe Coronary Stenosis. Ann Nucl Cardiol. 2019;5:47\u20139.","journal-title":"Ann Nucl Cardiol"},{"key":"2235_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.17996\/anc.20-00131","volume":"6","author":"K Kobayashi","year":"2020","unstructured":"Kobayashi K, Sakata Y, Miyauchi H, Ikeda Y, Nagasawa Y, Nakajima K, et al. The Diagnostic Criteria 2020 for Triglyceride Deposit Cardiomyovasculopathy. Ann Nucl Cardiol. 2020;6:99\u2013104.","journal-title":"Ann Nucl Cardiol"},{"key":"2235_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s12149-022-01787-9","volume":"36","author":"Z Chen","year":"2022","unstructured":"Chen Z, Nakajima K, Hirano K, Kamiya T, Yoshida S, Saito S, et al. Methods of calculating 123I-beta-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy. Ann Nucl Med. 2022;36:986\u201397.","journal-title":"Ann Nucl Med"},{"key":"2235_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12149-023-01863-8","volume":"38","author":"K Nakajima","year":"2024","unstructured":"Nakajima K, Miyauchi H, Hirano KI, Fujimoto S, Kawahito M, Iimori T, et al. Practice recommendation for measuring washout rates in (123)I-BMIPP fatty acid images. Ann Nucl Med. 2024;38:1\u20138.","journal-title":"Ann Nucl Med"},{"key":"2235_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17996\/anc.22-00172","volume":"9","author":"H Miyauchi","year":"2022","unstructured":"Miyauchi H, Ono R, Iimori T, Sawada K, Hoshi K, Hirano K, et al. Modified Algorithm Using Total Count for Calculating Myocardial Washout Rate in Single-Photon Emission Computerized Tomography. Ann Nucl Cardiol. 2022;9:19\u201325.","journal-title":"Ann Nucl Cardiol"},{"key":"2235_CR13","first-page":"e55125","volume":"16","author":"S Kurisu","year":"2024","unstructured":"Kurisu S, Fujiwara H. Assessing a Myocardial Area at Risk in Non-ST Elevation Acute Myocardial Infarction Without Wall Motion Abnormalities Using Cardiac Magnetic Resonance and Radionuclide Imaging. Cureus. 2024;16:e55125.","journal-title":"Cureus"},{"key":"2235_CR14","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s002590050313","volume":"25","author":"Y Kawai","year":"1998","unstructured":"Kawai Y, Tsukamoto E, Nozaki Y, Kishino K, Kohya T, Tamaki N. Use of 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction. Eur J Nucl Med. 1998;25:1390\u20135.","journal-title":"Eur J Nucl Med"},{"key":"2235_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1536\/ihj.13-180","volume":"55","author":"K Yoneyama","year":"2014","unstructured":"Yoneyama K, Akashi YJ, Kida K, Ashikaga K, Musha H, Suzuki K, et al. Metabolic planar imaging using 123I-beta-methyl-iodophenyl pentadecanoic acid identifies myocardial ischemic memory after intracoronary acetylcholine provocation tests in patients with vasospastic angina. Int Heart J. 2014;55:113\u20138.","journal-title":"Int Heart J"},{"key":"2235_CR16","first-page":"1934","volume":"36","author":"K Nakajima","year":"1995","unstructured":"Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med. 1995;36:1934\u201340.","journal-title":"J Nucl Med"},{"key":"2235_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1253\/circj.CJ-19-1131","volume":"85","author":"M Yamagishi","year":"2021","unstructured":"Yamagishi M, Tamaki N, Akasaka T, Ikeda T, Ueshima K, Uemura S, et al. JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases. Circ J. 2021;85:402\u2013572.","journal-title":"Circ J"},{"key":"2235_CR18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s12350-020-02321-y","volume":"29","author":"SI Sazonova","year":"2022","unstructured":"Sazonova SI, Atabekov TA, Batalov RE, Mishkina AI, Varlamova JV, Zavadovsky KV, et al. Prediction of appropriate ICD therapy in patients with ischemic heart failure. J Nucl Cardiol. 2022;29:680\u201391.","journal-title":"J Nucl Cardiol"},{"key":"2235_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0002-9149(91)90552-V","volume":"67","author":"AI McGhie","year":"1991","unstructured":"McGhie AI, Corbett JR, Akers MS, Kulkarni P, Sills MN, Kremers M, et al. Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol. 1991;67:236\u201342.","journal-title":"Am J Cardiol"},{"key":"2235_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/1756-185X.13508","volume":"22","author":"H Iida","year":"2019","unstructured":"Iida H, Hanaoka H, Okada Y, Kiyokawa T, Takakuwa Y, Yamada H, et al. A low perfusion-metabolic mismatch in 99mTl and 123I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvement. Int J Rheum Dis. 2019;22:1008\u201315.","journal-title":"Int J Rheum Dis"},{"key":"2235_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12149-021-01696-3","volume":"36","author":"M Morishima","year":"2022","unstructured":"Morishima M, Kiriyama T, Miyagi Y, Otsuka T, Fukushima Y, Kumita SI, et al. Serial change in perfusion-metabolism mismatch after coronary artery bypass grafting. Ann Nucl Med. 2022;36:244\u201354.","journal-title":"Ann Nucl Med"},{"key":"2235_CR22","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMc0805305","volume":"359","author":"K Hirano","year":"2008","unstructured":"Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G. Triglyceride deposit cardiomyovasculopathy. N Engl J Med. 2008;359:2396\u20138.","journal-title":"N Engl J Med"},{"key":"2235_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/eurheartj\/ehu417","volume":"36","author":"K Hirano","year":"2015","unstructured":"Hirano K, Ikeda Y, Sugimura K, Sakata Y. Cardiomyocyte steatosis and defective washout of iodine-123-beta-methyl iodophenyl-pentadecanoic acid in genetic deficiency of adipose triglyceride lipase. Eur Heart J. 2015;36:580.","journal-title":"Eur Heart J"},{"key":"2235_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/heartjnl-2020-318055","volume":"107","author":"K Nakajima","year":"2021","unstructured":"Nakajima K. Triglyceride deposit cardiomyovasculopathy: how to recognise a new disease entity. Heart. 2021;107:93\u20135.","journal-title":"Heart"},{"key":"2235_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12350-018-01585-9","volume":"28","author":"Y Yamada","year":"2021","unstructured":"Yamada Y, Nakano S, Gatate Y, Okano N, Muramatsu T, Nishimura S, et al. Feasibility of simultaneous 99mTc-tetrofosmin and 123I-BMIPP dual-tracer imaging with cadmium-zinc-telluride detectors in patients undergoing primary coronary intervention for acute myocardial infarction. J Nucl Cardiol. 2021;28:187\u201395.","journal-title":"J Nucl Cardiol"},{"key":"2235_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41824-025-00272-6","volume":"9","author":"T Shibutani","year":"2025","unstructured":"Shibutani T, Onoguchi M, Yoneyama H, Konishi T, Nakajima K. Simultaneous dual-isotope SPECT imaging using a cardiac cadmium-zinc-telluride camera with various Technetium-99 m to Iodine-123 ratios. EJNMMI Rep. 2025;9:36.","journal-title":"EJNMMI Rep"},{"key":"2235_CR27","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s00259-022-05749-1","volume":"49","author":"C Aoshima","year":"2022","unstructured":"Aoshima C, Fujimoto S, Kudo A, Kawaguchi YO, Takamura K, Matsue Y, et al. Clinical significance of 123I-BMIPP washout rate in patients with uncertain chronic heart failure. Eur J Nucl Med Mol Imaging. 2022;49:3129\u201339.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02235-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:04:22Z","timestamp":1790643862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2235"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02235-8","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. Nakajima worked in an endowed department funded by PDRadiopharma, Tokyo, Japan, Nihon Medi-Physics, Tokyo, Japan, and Siemens Healthcare, Tokyo, Japan, until March 2024.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee at Kaga Medical Center approved this study (Approval No. 2025 [R7]-7). The requirement for patient consent was waived due to the retrospective study design.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}